CompletedPhase 2NCT00018954
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Principal Investigator
- Ian Trevor Magrath, MD, FRCP, FRCPathNational Cancer Institute (NCI)
- Intervention
- asparaginase(drug)
- Eligibility
- All sexes
- Timeline
- 1992 – 2002
Study locations (5)
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States
- National Cancer Institute of Egypt, Cairo, Egypt
- Kidwai Memorial Institute of Oncology, Bangalore, India
- Cancer Institute (W.I.A.), Madras, India
- Tata Memorial Centre, Mumbai, India
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00018954 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.